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ABSTRACT
OBJECTIVE: To determine the distribution of total cholesterol, LDL cholesterol, HDL cholesterol, 
and triglycerides in Brazilian adolescents, as well as the prevalence of altered levels of such 
parameters.
METHODS: Data from the Study of Cardiovascular Risks in Adolescents (ERICA) were used. This 
is a country-wide, school-based cross-sectional study that evaluated 12 to 17-year old adolescents 
living in cities with over 100,000 inhabitants. The average and distribution of plasma levels of total 
cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides were evaluated. Dyslipidemia 
was determined by levels of total cholesterol ≥ 170 mg/dl, LDL cholesterol ≥ 130 mg/dl, HDL 
cholesterol < 45 mg/dL, or triglycerides ≥ 130 mg/dl. The data were analyzed by gender, age, and 
regions in Brazil.
RESULTS: We evaluated 38,069 adolescents – 59.9% of females, and 54.2% between 15 and 17 
years. The average values found were: total cholesterol = 148.1 mg/dl (95%CI 147.1-149.1), HDL 
cholesterol = 47.3 mg/dl (95%CI 46.7-47.9), LDL cholesterol = 85.3 mg/dl (95%CI 84.5-86.1), and 
triglycerides = 77.8 mg/dl (95%CI 76.5-79.2). The female adolescents had higher average levels 
of total cholesterol, LDL cholesterol, and HDL cholesterol, without differences in the levels of 
triglycerides. We did not observe any significant differences between the average values among 
12 to 14 and 15- to 17-year old adolescents. The most prevalent lipid alterations were low HDL 
cholesterol (46.8% [95%CI 44.8-48.9]), hypercholesterolemia (20.1% [95%CI 19.0-21.3]), and 
hypertriglyceridemia (7.8% [95%CI 7.1-8.6]). High LDL cholesterol was found in 3.5% (95%CI 
3.2-4.0) of the adolescents. Prevalence of low HDL cholesterol was higher in Brazil’s North and 
Northeast regions.
CONCLUSIONS: A significant proportion of Brazilian adolescents has alterations in their 
plasma lipids. The high prevalence of low HDL cholesterol and hypertriglyceridemia, especially in 
Brazil’s North and Northeast regions, must be analyzed in future studies, to support the creation 
of strategies for efficient interventions.
DESCRIPTORS: Adolescent. Dyslipidemias, epidemiology. Prevalence. Cardiovascular Diseases. 
Cross-Sectional Studies.
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INTRODUCTION
Cardiovascular diseases (CVD) are the main cause for morbidity and mortality in societies 
with Western lifestyles25. In Brazil, CVD is the main cause of death24. In addition of promoting 
great socioeconomic impacts to patients and their families, CVDs also imply high costs to 
the state, due to the high frequency of hospital admissions, medical leaves of absence, and 
early retirement. Such impact may be even higher in the next few years, as the mortality rate 
due to some forms of CVD is increasing in some of Brazilian regions1. Thus, controlling the 
risk factors for atherosclerotic disease, which are the pathophysiological base of coronary 
ischemic events and of a significant share of cerebrovascular ischemic events, is essential 
to change such scenario28.
The alterations of plasma lipids and their lipoproteins are associated with elevated 
cardiovascular risk8. Elevated cholesterol associated with low-density lipoprotein (LDLc) 
is closely correlated with increased cardiovascular risk, regardless of age11. Although the 
onset of atherothrombotic events usually takes place after the fourth decade of life, early 
exposure to hyperlipidemic environments may lead to lipid deposition on artery walls 
in the first weeks after birth16. Necropsy data reveal that high LDLc and low levels of 
cholesterol associated with high-density lipoprotein(HDLs) is associated with coronary 
atherosclerosis in adolescents and young adults15. Therefore, cardiovascular prevention 
must start in childhood and adolescence, and, to do that, it is necessary to identify the 
presence of risk factors in this population. 
In Brazil, population-based data on alterations in plasma lipids are scarce and generally have 
restrict casuistry, small samples, or very limited geographical areas19,23. The aim of this analysis 
was to determine the distribution of total cholesterol (TC), LDLc, HDLc, and triglycerides 
(TG) in Brazilian adolescents, as well as the prevalence of altered levels of those parameters.
METHODS
This work is part of the cross-sectional, nation-wide, school based Study of Cardiovascular 
Risks in Adolescents (ERICA) conducted in 2013-2014. The aim of ERICA was to estimate the 
prevalence of diabetes mellitus, obesity, cardiovascular risk factors, and markers of insulin 
resistance and inflammation in 12- to 17-year old adolescents attending schools in Brazilian 
cities with over 100,000 inhabitants. 
The research sample was stratified in 32 strata comprising 27 capitals and five sets of 
municipalities with over 100,000 inhabitants in each of Brazil’s five geographical regions. 
For each geographical stratum, the larger schools were, the more chances they had of being 
selected. On the other hand, the farther away from a state capital a school was, the fewer 
chances it had of being picked. The sample is representative of the population of teenage 
students at national and regional levels, and for the Brazilian capitals. Parameters such as the 
location of a school (urban or rural) and management (public or private) were also considered. 
That strategy allowed to concentrate the sample in the surrounding areas of capitals, reducing 
costs and making the study logistics easier, especially regarding the collection of blood and 
the standardization of pre-analytical procedures. In total, 1,247 schools (out of 1,251 selected) 
were evaluated in 122 Brazilian municipalities (out of 124 selected). Further details on the 
sampling process are found in the publication by Vasconcellos et al.27
In the second sampling stage, we selected three groups from each school, considering 
combinations of sessions (morning and afternoon) and eligible grades (seventh, eighth, 
and ninth grade of elementary school and first, second, and third grade of high school). 
All students from selected groups were invited to take part in ERICA, but only morning 
session students took part in the blood collection as they were required to be fasting. 
Adolescents outside the age range between 12 and 17 years, pregnant ones, and physically 
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or mentally-challenged adolescents (either temporarily or permanently) were excluded from 
the analyses for not being considered eligible. 
The collected data were obtained through the use of self-administered questionnaires in 
handheld computers (PDA – personal digital assistant). The questionnaire had around 100 
questions divided in 11 blocks: sociodemographic aspects, occupational activities, physical 
activity, diet habits, smoking, use of alcohol, reproductive health, oral health, sleeping 
and waking hours during the week and on weekends, physical morbidity (self-reported), 
and mental health. Also, data regarding weight, height, waist and arm perimeters, arterial 
pressure, and food intake – this one through the reported 24-hour. dietary recall. Details on 
the experiment were previously described2.
A standardized research protocol was adopted for blood collection and applied in the 
27 centers. We used only a reference laboratory, concentrating all biochemical analyses 
of the study, with strict quality assurance and support from local partner laboratories 
that managed the collection and receiving of samples. This allowed for measures to be 
standardized and results to be made uniform. All laboratories received the instructions on 
the protocol to be followed in all steps, from scheduling to transportation to the central 
unit, including labeled kits for collecting blood of each adolescent. We instructed the 
adolescents to fast for 12 hours before the collection and applied a questionnaire before 
the exam to confirm students had fasted.
The exams conducted were: TG, HDLc, glucose, glycated hemoglobin, fasting insulin, and TC. 
LDLc was calculated by Friedewald’s formula4. Table 1 presents the methods used to analyze 
each exam and adopted cutoff points28. Dyslipidemia was defined upon the presence of high TC, 
LDLc, or TG levels, or low HDLc levels. The glucose parameters are not shown in this article.
This analysis included information on gender, age in years, and age range (12-14 and 15-17), type of 
school (public or private), and regions in Brazil (North, Northeast, Midwest, Southeast, and South).
Prevalences and 95% confidence intervals (95%CI) were calculated for each component in 
the lipid profile by gender, age, and type of school, covering the national and the regional 
context. Averages and proportions were described for the quantitative and categorical 
variables, respectively, with 95%CI in both cases. 
The distribution of characteristics was adjusted according to the sampling design, by 
using complex statistical sampling routes, as the sample of ERICA employs stratification 
(each of the 27 capital cities and five strata with the set of municipalities with over 100,000 
inhabitants from each of Brazil’s five regions) and clustering (by school and by group) 
in its selection stages. Sampling weights were calculated by the multiplication of the 
inverse inclusion probabilities in each stage of the sampling and calibrated by considering 
the projected number of adolescents enrolled in schools located in the geographical 
strata that were considered in December 31, 2013. A post-stratification estimator was 
used – it modifies the natural weight of the design through a calibration factor. That 
factor corresponds to the ratio between the total population and the total estimated by 
the natural weight of the design for the post-stratum or domain of estimation considered. 




Triglycerides (mg/dL) Enzyme kinetics ADVIA 2400 Siemens < 100 100-129 ≥ 130
Cholesterol (mg/dL) Enzyme kinetics ADVIA 2400 Siemens < 150 150-169 ≥ 170
LDLc (mg/dL) Friedewald Equation (calculated) < 100 100-129 ≥ 130
HDLc (mg/dL) Enzyme colorimetric assay ADVIA 2400 Siemens ≥ 45 - -
LDLc: low-density lipoprotein cholesterol; HDLc: high-density lipoprotein cholesterol
a Sociedade Brasileira de Patologia (Brazilian Pathology Society).
b V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis, 2013.
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Further details on the sampling design can be found in Vasconcellos et al27. The analyses 
were conducted in statistical software Stataa, version 14.0.
The study was approved by the Research Ethics Committees (REC) of the Central Coordination 
of the study (Institute of Collective Health Studies of the Universidade Federal do Rio de 
Janeiro) and of the institutions responsible for conducting the study in each Brazilian state. 
All adolescents interviewed and examined handed in informed consent terms signed by 
their legal guardians.
RESULTS
We analyzed the data from 38,069 adolescents, who answered the questionnaire and had 
the lipid profiles measured in ERICA. The national coverage for blood collection was 52.7%. 
Table 2 describes the characteristics of the sample. Around two thirds of the adolescents 
were females, and most of them studied at public schools.
The distribution of lipid values by gender in the sample is presented in Figure 1, and the 
averages are shown in Table 3. Generally speaking, and considering the stratification by 
gender and age, the averages are very close to one another for all plasma lipids analyzed. 
The values from the female adolescents are always higher than the ones of male adolescents.
In the assessment of dyslipidemia prevalence, a higher percentage of female adolescents 
had high levels of TC and LDLc. On the other hand, the prevalence of low HDLc levels was 
lower for the female gender. 
We observe no differences between genders regarding prevalence of hypertriglyceridemia and 
also no differences in the average lipid levels of the youngest adolescents (12 to 14 years old) 
a Stata Corp. Stata: statistical 
software for professionals. 
Version 14.0. College Station, 
Texas; 2015.
Table 2. Sample distribution by gender, age range, type of school (public or private), and geographical 







12-14 years 17,434 45.8
15-17 years 20,635 54.2
Gender and age
Male, 12-14 years 7,140 18.8
Male, 15-17 years 8,107 21.3
Female, 12-14 years 10,294 27.0
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as compared to the oldest ones (15 to 17 years). Likewise, the prevalences of dyslipidemias 
were not different between those groups.
Figure 2 shows the prevalences of dyslipidemia according to Brazilian regions. No 
differences for TC, LDLc, and TG were observed among the five regions, with similar 
percentages of alterations. Prevalences of low HDL cholesterol were high in Brazil’s 








































































































































































































































































































































































































































































































TC: total cholesterol; HDLc: high-density lipoprotein cholesterol; LDLc: low-density lipoprotein cholesterol; TG: triglycerides
Figure 1. Distribution of blood levels TC, HDLc, LDLc, and TG in adolescents. ERICA, Brazil, 2013-2014.
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Table 3. Averages and 95%CI of plasma lipids, and prevalence and 95%CI of threshold values and values altered by gender and age range 
and estimated altered populationa,b. ERICA, Brazil, 2013-2014. 
Lipids




mg/dl 95%CI % 95%CI % 95%CI
Total cholesterol
All 148.1 147.1-149.1 24.2 22.7-25.8 20.1 19.0-21.3 2,940,705
Male 143.6 142.4-144.8 22.7 20.4-25.2 15.3 13.9-16.9 1,256,102
Female 152.6 151.4-153.9 25.7 24.5-27.0 24.9 23.4-26.5 1,684,602
12-14 years 149.4 148.0-150.7 25.8 24.3-27.4 20.7 19.1-22.5 937,793
15-17 years 147.1 145.8-148.3 22.8 20.8-24.9 19.6 18.0-21.2 2,002,911
LDLc
All 85.3 84.5-86.1 19.5 18.5-20.5 3.5 3.2-4.0 1,526,733
Male 83.4 82.2-84.5 17.4 16.0-18.9 2.9 2.3-3.6 669,805
Female 87.2 86.3-88.1 21.5 20.2-22.9 4.3 3.7-4.9 856,928
12-14 years 86.2 85.1-87.3 20.6 19.0-22.4 3.7 3.1-4.4 467,877
15-17 years 84.5 83.5-85.5 18.4 17.2-19.7 3.4 2.9-4.1 1,058,856
Triglycerides
All 77.8 76.5-79.2 12.0 11.0-13.0 7.8 7.1-8.6 1,312,329
Male 76.4 74.7-78.1 10.9 9.8-12.2 7.6 6.5-8.8 610,449
Female 79.3 77.8-80.7 13.0 11.8-14.2 8.1 7.3-9.0 701,880
12-14 years 78.9 76.7-81.0 12.7 11.0-14.6 8.3 7.2-9.5 434,638
15-17 years 76.9 75.8-78.1 11.3 10.2-12.4 7.4 6.6-8.4 877,690
Low %
HDLc
All 47.3 46.7-47.9 46.8 44.8-48.9 - - 3,104,161
Male 44.9 44.4-45.5 55.9 53.7-58.2 - - 1,256,003
Female 49.6 48.9-50.3 37.8 35.4-40.2 - - 1,848,158
12-14 years 47.4 46.7-48.1 45.0 42.3-47.8 - - 819,980
15-17 years 47.2 46.4-48.0 48.4 45.9-50.8 - - 2,284,181
LDLc: low-density lipoprotein cholesterol; HDLc: high-density lipoprotein cholesterol
a alteration = higher threshold values.
b The population estimates for the domains were obtained through the processing of microdata from IBGE’s Demographic Sensuses 2000 and 2010.
TC: total cholesterol; HDLc: high-density lipoprotein cholesterol; LDLc: low-density lipoprotein 
cholesterol; TG: triglycerides; N: North; NE: Northeast; MW: Midwest; SE: Southeast; S: South
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DISCUSSION
Although measures for nationwide primary prevention may seem to be reducing some 
types of CVD in Brazil21, the economic impact of these diseases in our environment is 
significant. The development of effective strategies for cardiovascular prevention depends 
on the proper acknowledgment of its risk factors in the country. ERICA is the largest 
study on the prevalence of cardiovascular risk factors in adolescents ever conducted in 
Brazil. The prevalences of lipid alterations were high in the Brazilian adolescents who 
study in municipalities with over 100,000 inhabitants, especially the ones of low HDLc 
levels and high TC levels. 
High cholesterol is correlated with cardiovascular risk11 and, even in children and 
adolescents, is associated with the presence of sub-clinical atherosclerosis12 and with 
the risk of dyslipidemia at adult ages20. In ERICA, the definition of altered values followed 
the references of a national guideline28 that differs from other proposals, such as the 
National Cholesterol Education Program (NCEP)17. These differences in the definitions 
of dyslipidemia must be considered when comparing the results from ERICA with other 
populations. Comparisons are even harder due to the scarcity of nationwide data in most 
countries. The current prevalence of dyslipidemia in children and adolescents in the United 
States and its time series between 1999 and 2012 have been recently published10. Around 
one fifth of American adolescents have some sort of lipid alteration, and this percentage 
decreased in the evaluated period. In ERICA, the same percentage is only found for TC. 
Nonetheless, a significantly higher proportion has low HDLc levels in Brazil. Although it 
involves a population of very distinct ethnicities, a nationwide study conducted in South 
Korea found average TC, LDLc, HDLc, and TG values similar to the ones found in our 
population29. In HELENA, a multicenter, European study with students at the same age 
range as ERICA, lower TG levels were observed as compared to the ones from ERICA 
(68 mg/dL [SD = 34]) for the whole population, with similar patterns of gender distribution: 
63 mg/dL (SD = 31) in the male gender and 73 mg/dL (SD = 36) in the female gender22.
In turn, the National Health and Nutrition Examination Survey (NHANES) III (1988-1994) – a 
North-American study – found higher lipid levels than the ones of ERICA for all parameters, 
TC 163 mg/dL (standard error [SE] = 1.0); LDLc 95 mg/dL (SE = 1.6); HDLc 49 mg/dL (SE = 0.4), 
and TG 93 mg/dL (SE = 2.4)6. 
The coverage and the national representativeness of ERICA study found never-before-seen 
data in our population. Distinct aspects of age ranges and genders were observed. No 
consensus exist on whether using single reference values – as used in ERICA and more 
widespread in the clinical routine – or using curves with specific values for gender and age 
is ideal for defining the presence of dyslipidemia in adolescents.
Magnussen et al.13 analyzed which strategy among the available ones would be best to 
predict the presence of dyslipidemia in adulthood, by using the reference values of NCEP17 
and curves for gender and age originated from NHANES7. Although the evaluation through 
curves has allowed for better predicting low HDLc levels during adulthood, all the remaining 
lipid parameters were better predicted by the reference values of NCEP (similar to the ones 
used in ERICA). In ERICA, age was not a factor that determined significant differences. 
The average levels TC, LDLc, HDLc, and TG did not differ among 12-14 and 15-17-year old 
adolescents, corroborating the idea that single reference values for adolescents may be used 
to better identify lipid alterations28. That information reinforces the need for properly knowing 
the reference values used herein by the ones to provide medical care to such population, 
which is not observed nowadays5.
In this initial analysis, no specific curves using year-to-year ages were used, but the studies 
that used them showed slightly reduced TC, LDLc, and HDLc in the early adolescence of 
male subjects, whose levels returned to their previous values at the end of adolescence. 
On the other hand, in female adolescents, age does not seem to have a direct and rising 
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relationship with LDLc levels7. This difference between genders became evident in ERICA. 
The TC, LDLc, and TG average values were higher in female adolescents, as well as the HDLc 
values. Consequently, the prevalence of high TC, LDLc, and TG levels were also higher in 
the female gender, which had the smallest prevalence of low HDLc.
In this study, we found regional differences regarding prevalence of dyslipidemias. Prevalence 
of low HDLc cholesterol was significantly higher in Brazil’s North and Northeast regions. 
Prevalence of high TG was also higher in those two regions, but confidence intervals were 
juxtaposed. In Recife, Northeast region, a study conducted with public school students also 
found high prevalence of low HDLc (56.0% [95%CI 51.3-60.5])19. The combination of those 
metabolic alterations, low HDLc, and high TG is usually present, especially in obese patients3 
and patients with improper lifestyles. Together, those parameters are markers of the presence 
of smaller, denser, and more proatherogenic LDL molecules. That pattern of dyslipidemia, in 
which there is little alteration of LDL levels with predominance of HDLc and TG alterations, 
was already described as a predominant pattern during childhood9. Recent data of increased 
mortality due to cardiac ischemic diseases in those regions1 suggest that different regions in 
Brazil may be in distinct stages of the epidemiological transition process, which was already 
well described in different countries in the Americas14. Future analyses in the same population 
will allow for better understanding the factors associated with that pattern of atherogenic 
dyslipidemia that was observed in adolescents from Brazil’s North and Northeast regions. 
Although it had been the least frequent alteration, the finding of 3.6% of high LDLc 
prevalence (≥ 130 mg/dl) deserves special attention. The presence of LDLc levels in children 
and adolescents must be the first step for acknowledging family hypercholesterolemia, 
a disease with genetic causes and autosomal dominant onset, which affects around 1 in 
500 individuals. In Brazil, at least 1.0% of the population with family hypercholesterolemia 
is estimated to be correctly identified18. Adolescents suffering from that disease are exposed 
to a high lipid burden from birth, and need specialized medical supervision. Without proper 
treatment, around 50.0% of men will have a coronary event before the age of 5026. Therefore, 
the data from ERICA are a unique opportunity for evaluating the real prevalence of family 
hypercholesterolemia in Brazil. From the identification of index cases, planning a cascade 
screening strategy will be possible.
This initial analysis of the lipid data from ERICA aimed at describing the distributions of 
lipids and dyslipidemias in teenage students of Brazilian municipalities with over 100,000 
inhabitants. Investigating factors associated with dyslipidemias and their combinations, 
such as food intake characteristics, lifestyle, and history of family morbidity may be enabled 
by future analyses. Although ERICA is a sectional study, as it deals with a population of 
adolescents who still do not have clinical complications or mortality due to dyslipidemias, 
it is unlikely that associations that may be observed result from survival bias. 
In short, lipid alterations are frequent in Brazilian adolescents. Lifestyle interventions are 
fundamental to improve this scenario, and they are generally effective in the short run. The data 
suggest that, even though prevention strategies are planned countrywide, it is fundamental 
to recognize regional differences, so that these strategies can be properly executed.
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